Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- PMID: 37447156
- PMCID: PMC10343446
- DOI: 10.3390/nu15132830
Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Abstract
Dysmenorrhea causes pain and inconvenience during menstruation. In addition to medication, natural compounds are widely used to relieve various types of pain. In this study, we aimed to assess the effects of vitamin D (vit. D) supplementation in relieving the symptoms of primary dysmenorrhea. A comprehensive systematic database search of randomized controlled trials (RCTs) was performed. Oral forms of vit. D supplementation were included and compared with a placebo or standard care. The degree of dysmenorrhea pain was measured with a visual analogue scale or numerical rating scale. Outcomes were compared using the standardized mean difference (SMD) and 95% confidence intervals (CIs) in a meta-analysis. RCTs were assessed using the Cochrane risk-of-bias v2 (RoB 2) tool. The meta-analysis included 8 randomized controlled trials involving 695 participants. The results of the quantitative analysis showed a significantly lower degree of pain in the vit. D versus placebo in those with dysmenorrhea (SMD: -1.404, 95% CI: -2.078 to -0.731). The results of subgroup analysis revealed that pain lessened when the average weekly dose of vit. D was over 50,000 IU, in which dysmenorrhea was relieved regardless of whether vit. D was administered for more or less than 70 days and in any dose interval. The results revealed that vit. D treatment substantially reduced the pain level in the primary dysmenorrhea population. We concluded that vit. D supplementation is an alternative treatment for relieving the pain symptoms of dysmenorrhea.
Keywords: Cochrane risk-of-bias (RoB 2); dysmenorrhea; pain degree; pain relief; randomized controlled trials (RCTs); systemic review meta-analysis (SRMA); vitamin D.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Herbal and dietary therapies for primary and secondary dysmenorrhoea.Cochrane Database Syst Rev. 2001;(3):CD002124. doi: 10.1002/14651858.CD002124. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124. doi: 10.1002/14651858.CD002124.pub2. PMID: 11687013 Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Acupuncture for dysmenorrhoea.Cochrane Database Syst Rev. 2016 Apr 18;4(4):CD007854. doi: 10.1002/14651858.CD007854.pub3. Cochrane Database Syst Rev. 2016. PMID: 27087494 Free PMC article.
Cited by
-
Risk Factors of Primary Dysmenorrhea in Female Adolescent Basketball Players Related to Dietary, Hormonal, and Immuno-Metabolic Factors and Disordered Eating Attitudes.Nutrients. 2025 Mar 28;17(7):1190. doi: 10.3390/nu17071190. Nutrients. 2025. PMID: 40218947 Free PMC article.
-
Single-cell sequencing combined with urinary multi-omics analysis reveals that the non-invasive biomarker PRDX5 regulates bladder cancer progression through ferroptosis signaling.BMC Cancer. 2025 Mar 24;25(1):533. doi: 10.1186/s12885-025-13881-y. BMC Cancer. 2025. PMID: 40122834 Free PMC article.
-
piRNAs and circRNAs acting as diagnostic biomarkers in clear cell renal cell carcinoma.Sci Rep. 2025 Mar 5;15(1):7774. doi: 10.1038/s41598-025-90874-8. Sci Rep. 2025. PMID: 40044829 Free PMC article.
-
Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients.J Cell Mol Med. 2025 Apr;29(7):e70504. doi: 10.1111/jcmm.70504. J Cell Mol Med. 2025. PMID: 40193290 Free PMC article.
-
Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 7. doi: 10.1007/s00210-025-04404-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40622592 Review.
References
-
- Nnoaham K.E., Hummelshoj L., Webster P., d’Hooghe T., de Cicco Nardone F., de Cicco Nardone C., Jenkinson C., Kennedy S.H., Zondervan K.T. Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertil. Steril. 2011;96:366–373.e368. doi: 10.1016/j.fertnstert.2011.05.090. - DOI - PMC - PubMed
-
- Ayan M., Sogut E., Tas U., Erdemir F., Sahin M., Suren M., Kaya Z., Demirturk F. Pain levels associated with renal colic and primary dysmenorrhea: A prospective controlled study with objective and subjective outcomes. Arch. Gynecol. Obstet. 2012;286:403–409. doi: 10.1007/s00404-012-2316-4. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical